Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Completed1
Recruiting1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 32 (66.7%)

Trials by Status

completed125%
recruiting125%
enrolling_by_invitation125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_3

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

NCT05303064
enrolling_by_invitationphase_3

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

NCT04987229
unknown

An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)

NCT07744113
completedphase_1

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

NCT04987658

Clinical Trials (4)

Showing 4 of 4 trials
NCT05303064Phase 3

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Recruiting
NCT04987229Phase 3

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Enrolling By Invitation
NCT07744113

An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)

Unknown
NCT04987658Phase 1

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4